FDA Inspection 1173018 — Laboratory Corporation Of America Holdings
The FDA completed an inspection of Laboratory Corporation Of America Holdings on Jun 15, 2022 in Raritan, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 15, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Raritan, NJ (United States)